American Stock Exchange to Trade Options on Bioenvision, Inc.
January 20 2006 - 3:52PM
PR Newswire (US)
NEW YORK, Jan. 20 /PRNewswire/ -- The American Stock Exchange(R)
(Amex) (R) will launch trading in options on Monday, January 23,
2006 on the following Nasdaq Stock Market listed stocks of: *
Bioenvision, Inc. (Option Symbol: BQN/Stock Symbol: BIVN)
Bioenvision, Inc. options will open with position limits of
7,500,000 shares. The options will trade on the March expiration
cycle. The specialist will be Kellogg Capital Group, LLC.
Bioenvision, Inc. is a biopharmaceutical company primarily focused
on the research and development of products and technologies for
the treatment of cancer. The company also performs research on
anti-immune diseases. For more information on any Amex-listed
company, please visit http://www.amex.com/. The American Stock
Exchange(R) (Amex(R)) is the only primary exchange that offers
trading across a full range of equities, options and exchange
traded funds (ETFs), including structured products and HOLDRS(SM).
In addition to its role as a national equities market, the Amex is
the pioneer of the ETF, responsible for bringing the first domestic
product to market in 1993. Leading the industry in ETF listings,
the Amex lists 150 ETFs. The Amex is also one of the largest
options exchanges in the U.S., trading options on broad-based and
sector indexes as well as domestic and foreign stocks. For more
information, please visit http://www.amex.com/. DATASOURCE:
American Stock Exchange CONTACT: Kelsey Hubbard, American Stock
Exchange, +1-212-306-1640, Web site: http://www.amex.com/
Copyright